Medicine
Actimmune 100 mcg/0.5 mL injection
Actimmune 100 mcg/0.5 mL injection is a prescription medicine containing Interferon gamma-1b for subcutaneous use, marketed by Horizon Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store vials in the refrigerator at 2 to 8 °C (36 °F – 46 °F). Do Not Freeze…
Key facts
- Active ingredient (INN)
- Interferon gamma-1b
- Brand
- Actimmune
- Strength
- 100 mcg/0.5 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 12 vials of 0.5 mL
- Marketing authorisation holder
- Horizon Therapeutics
- Manufacturer
- Horizon Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store vials in the refrigerator at 2 to 8 °C (36 °F – 46 °F). Do Not Freeze. Do not return to the refrigerator. An unused vial of ACTIMMUNE can be stored at room temperature up to 12 hours prior to use. Do Not Shake.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L03AB03 Interferon gamma-1b
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 December 2013
- Identifiers
- RxCUI 240448, 751970DailyMed set ID 5d0b1256-1981-4519-94f4-a4a2f98bd8a3NDC 75987-111Application BLA103836
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 12 vial, single-dose in 1 carton / .5 mL in 1 vial, single-dose | 75987-111-11 | Horizon Therapeutics | 1 December 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 February 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Interferon gamma-1b is an interferon gamma indicated for reducing the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD), among other approved uses. It is available as injection for subcutaneous use. MedsAcross supplies Interferon gamma-1b for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Interferon gamma-1bFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ACTIMMUNE prescribing information (Horizon Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Actimmune 100 mcg/0.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.